Literature DB >> 20064938

PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.

Olga Loseva1, Ann-Sofie Jemth, Helen E Bryant, Herwig Schüler, Lari Lehtiö, Tobias Karlberg, Thomas Helleday.   

Abstract

The PARP-3 protein is closely related to the PARP-1 and PARP-2 proteins, which are involved in DNA repair and genome maintenance. Here, we characterized the biochemical properties of human PARP-3. PARP-3 is able to ADP-ribosylate itself as well as histone H1, a previously unknown substrate for PARP-3. PARP-3 is not activated upon binding to DNA and is a mono-ADP-ribosylase, in contrast to PARP-1 and PARP-2. PARP-3 interacts with PARP-1 and activates PARP-1 in the absence of DNA, resulting in synthesis of polymers of ADP-ribose. The N-terminal WGR domain of PARP-3 is involved in this activation. The functional interaction between PARP-3 and PARP-1 suggests that it may have a role in DNA repair. However, here we report that PARP-3 small interfering RNA-depleted cells are not sensitive to the topoisomerase I poison camptothecin, inducing DNA single-strand breaks, and repair these lesions as efficiently as wild-type cells. Altogether, these results suggest that the interaction between PARP-1 and PARP-3 is unrelated to DNA single-strand break repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064938      PMCID: PMC2832956          DOI: 10.1074/jbc.M109.077834

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.

Authors:  Henning Kleine; Elzbieta Poreba; Krzysztof Lesniewicz; Paul O Hassa; Michael O Hottiger; David W Litchfield; Brian H Shilton; Bernhard Lüscher
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

Review 2.  The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases.

Authors:  Paul O Hassa; Michael O Hottiger
Journal:  Front Biosci       Date:  2008-01-01

3.  Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.

Authors:  Zhihua Tao; Peng Gao; David W Hoffman; Hung-Wen Liu
Journal:  Biochemistry       Date:  2008-05-02       Impact factor: 3.162

4.  PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination.

Authors:  Helen E Bryant; Eva Petermann; Niklas Schultz; Ann-Sofie Jemth; Olga Loseva; Natalia Issaeva; Fredrik Johansson; Serena Fernandez; Peter McGlynn; Thomas Helleday
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

5.  Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.

Authors:  Lari Lehtiö; Ann-Sofie Jemth; Ruairi Collins; Olga Loseva; Andreas Johansson; Natalia Markova; Martin Hammarström; Alex Flores; Lovisa Holmberg-Schiavone; Johan Weigelt; Thomas Helleday; Herwig Schüler; Tobias Karlberg
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

6.  Assessment of PARP-3 distribution in tissues of cynomolgous monkeys.

Authors:  Michèle Rouleau; Mohamed El-Alfy; Marie-Hélène Lévesque; Guy G Poirier
Journal:  J Histochem Cytochem       Date:  2009-03-30       Impact factor: 2.479

Review 7.  DNA repair pathways as targets for cancer therapy.

Authors:  Thomas Helleday; Eva Petermann; Cecilia Lundin; Ben Hodgson; Ricky A Sharma
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

8.  Large-scale mapping of human protein-protein interactions by mass spectrometry.

Authors:  Rob M Ewing; Peter Chu; Fred Elisma; Hongyan Li; Paul Taylor; Shane Climie; Linda McBroom-Cerajewski; Mark D Robinson; Liam O'Connor; Michael Li; Rod Taylor; Moyez Dharsee; Yuen Ho; Adrian Heilbut; Lynda Moore; Shudong Zhang; Olga Ornatsky; Yury V Bukhman; Martin Ethier; Yinglun Sheng; Julian Vasilescu; Mohamed Abu-Farha; Jean-Philippe Lambert; Henry S Duewel; Ian I Stewart; Bonnie Kuehl; Kelly Hogue; Karen Colwill; Katharine Gladwish; Brenda Muskat; Robert Kinach; Sally-Lin Adams; Michael F Moran; Gregg B Morin; Thodoros Topaloglou; Daniel Figeys
Journal:  Mol Syst Biol       Date:  2007-03-13       Impact factor: 11.429

9.  Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.

Authors:  Matthias Altmeyer; Simon Messner; Paul O Hassa; Monika Fey; Michael O Hottiger
Journal:  Nucleic Acids Res       Date:  2009-04-16       Impact factor: 16.971

Review 10.  The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series.

Authors:  Antoinette Hakmé; Heng-Kuan Wong; Françoise Dantzer; Valérie Schreiber
Journal:  EMBO Rep       Date:  2008-10-17       Impact factor: 8.807

View more
  60 in total

1.  Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.

Authors:  Christian Boehler; Laurent R Gauthier; Oliver Mortusewicz; Denis S Biard; Jean-Michel Saliou; Anne Bresson; Sarah Sanglier-Cianferani; Susan Smith; Valérie Schreiber; François Boussin; Françoise Dantzer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

2.  Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm.

Authors:  Anthony Leung; Tanya Todorova; Yoshinari Ando; Paul Chang
Journal:  RNA Biol       Date:  2012-05-01       Impact factor: 4.652

Review 3.  PARP inhibitor treatment in ovarian and breast cancer.

Authors:  Marcie K Weil; Alice P Chen
Journal:  Curr Probl Cancer       Date:  2011 Jan-Feb       Impact factor: 3.187

Review 4.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

Review 5.  Functions of the poly(ADP-ribose) polymerase superfamily in plants.

Authors:  Rebecca S Lamb; Matteo Citarelli; Sachin Teotia
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 6.  Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics.

Authors:  Jin-xue He; Chun-hao Yang; Ze-hong Miao
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

Review 7.  The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival.

Authors:  T Jubin; A Kadam; M Jariwala; S Bhatt; S Sutariya; A R Gani; S Gautam; R Begum
Journal:  Cell Prolif       Date:  2016-06-22       Impact factor: 6.831

8.  Drug Monographs: Olaratumab and Rucaparib.

Authors:  Dominic A Solimando; J Aubrey Waddell
Journal:  Hosp Pharm       Date:  2017-04

9.  Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes.

Authors:  Matteo Citarelli; Sachin Teotia; Rebecca S Lamb
Journal:  BMC Evol Biol       Date:  2010-10-13       Impact factor: 3.260

Review 10.  Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Authors:  Maria Manuela Rosado; Elisabetta Bennici; Flavia Novelli; Claudio Pioli
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.